519
Views
5
CrossRef citations to date
0
Altmetric
Review

A Compendium of Perspectives on Diabetes: A Challenge for Sustainable Health in the Modern Era

, , , , , & show all
Pages 2775-2787 | Published online: 17 Jun 2021

References

  • DeFronzo RA , Ferrannini E , Zimmet P , Alberti G . International Textbook of Diabetes Mellitus . John Wiley & Sons; 2015.
  • IDF Diabetes Atlas. IDF diabetes atlas, 9th edn. Brussels and Belgium; 2019. Available from: https://www.diabetesatlas.org. Accessed 5 11, 2021.
  • Zimmet PZ . Diabetes and its drivers: the largest epidemic in human history? Clin Diabetes Endocrinol . 2017;3(1):1. doi:10.1186/s40842-016-0039-3 28702255
  • International Diabetes Federation. IDF diabetes atlas 8th edition. IDF Executive Office; 2017. Available from: http://www.diabetesatlas.org/. Accessed 5 11, 2021.
  • Goyal R , Jialal I . Diabetes mellitus type 2. In: StatPearls . Treasure Island (FL): StatPearls Publishing; 2020.
  • American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes—2020. Diabetes Care . 2020;43(Supplement 1):S14–S31. doi:10.2337/dc20-S002.31862745
  • Mekala KC , Bertoni AG . Chapter 4 - epidemiology of diabetes mellitus. In: Orlando G , Piemonti L , Ricordi C , Stratta RJ , Gruessner RWG , editors. Transplantation, Bioengineering, and Regeneration of the Endocrine Pancreas . Academic Press; 2020:49–58.
  • Punthakee Z , Goldenberg R , Katz P . Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome. Can J Diabetes . 2018;42:S10–S15. doi:10.1016/j.jcjd.2017.10.003 29650080
  • Zheng Y , Ley SH , Hu FB . Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol . 2018;14(2):2. doi:10.1038/nrendo.2017.151
  • American Diabetes Association. 3. Prevention or delay of type 2 diabetes: standards of medical care in diabetes—2020. Diabetes Care . 2020;43(Supplement 1):S32–S36. doi:10.2337/dc20-S003.31862746
  • Vaiserman AM . Early-Life nutritional programming of type 2 diabetes: experimental and quasi-experimental evidence. Nutrients . 2017;9(3):236. doi:10.3390/nu9030236
  • Bhutta ZA . Early nutrition and adult outcomes: pieces of the puzzle. Lancet . 2013;382(9891):486–487. doi:10.1016/S0140-6736(13)60716-3 23541369
  • International Diabetes Federation. Diabetes Atlas . Brussels: International Diabetes Federation; 2003.
  • Lovic D , Piperidou A , Zografou I , Grassos H , Pittaras A , Manolis A . The growing epidemic of diabetes mellitus. 2020. Available from: https://www.ingentaconnect.com/content/ben/cvp/2020/00000018/00000002/art00003. Accessed 3 15, 2020
  • Yang W , Lu J , Weng J , et al. Prevalence of diabetes among men and women in China. N Engl J Med . 2010;362(12):1090–1101. doi:10.1056/NEJMoa0908292 20335585
  • Abuyassin B , Laher I . Diabetes epidemic sweeping the Arab world. World J Diabetes . 2016;7(8):165–174. doi:10.4239/wjd.v7.i8.165 27114755
  • International Diabetes Federation. IDF Diabetes Atlas . Brussels: International Diabetes Federation, Executive Office; 2011.
  • Zimmet PZ , Magliano DJ , Herman WH , Shaw JE . Diabetes: a 21st century challenge. Lancet Diabetes Endocrinol . 2014;2(1):56–64. doi:10.1016/S2213-8587(13)70112-8 24622669
  • Tillin T , Hughes AD , Godsland IF , et al. Insulin resistance and truncal obesity as important determinants of the greater incidence of diabetes in Indian Asians and African Caribbeans compared with Europeans: the Southall and Brent REvisited (SABRE) cohort. Diabetes Care . 2013;36(2):383–393. doi:10.2337/dc12-0544 22966089
  • Wändell PE , Johansson SE , Gåfvels C , Hellénius ML , de Faire U , Sundquist J . Estimation of diabetes prevalence among immigrants from the Middle East in Sweden by using three different data sources. Diabetes Metab . 2008;34(4):328–333. doi:10.1016/j.diabet.2008.01.012 18539497
  • Grant P . Management of diabetes in resource-poor settings. Clin Med . 2013;13(1):27–31. doi:10.7861/clinmedicine.13-1-27
  • van der Gronde T , Uyl-de Groot CA , Pieters T . Addressing the challenge of high-priced prescription drugs in the era of precision medicine: a systematic review of drug life cycles, therapeutic drug markets and regulatory frameworks. PLoS One . 2017;12(8). doi:10.1371/journal.pone.0182613
  • Campbell MD , Sathish T , Zimmet PZ , et al. Benefit of lifestyle-based T2DM prevention is influenced by prediabetes phenotype. Nat Rev Endocrinol . 2020;16:395–400. doi:10.1038/s41574-019-0316-1.32060416
  • Saeedi P , Petersohn I , Salpea P , et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas, 9th edition. Diabetes Res Clin Pract . 2019;157:107843. doi:10.1016/j.diabres.2019.107843 31518657
  • Zhou B , Lu Y , Hajifathalian K , et al. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants. Lancet . 2016;387(10027):1513–1530. doi:10.1016/S0140-6736(16)00618-8 27061677
  • Ogurtsova K , da Rocha Fernandes JD , Huang Y , et al. IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract . 2017;128:40–50. doi:10.1016/j.diabres.2017.03.024 28437734
  • Kautzky-Willer A , von Euler M , Oertelt-Prigione S . Editorial: sex and gender aspects in diabetes. Front Endocrinol . 2019;10. doi:10.3389/fendo.2019.00813.
  • Dagenais GR , Gerstein HC , Zhang X , et al. Variations in diabetes prevalence in low-, middle-, and high-income countries: results from the prospective urban and rural epidemiological study. Diabetes Care . 2016;39(5):780–787. doi:10.2337/dc15-2338 26965719
  • Goryakin Y , Rocco L , Suhrcke M . The contribution of urbanization to non-communicable diseases: evidence from 173 countries from 1980 to 2008. Econ Hum Biol . 2017;26:151–163. doi:10.1016/j.ehb.2017.03.004 28410489
  • Hwang CK , Han PV , Zabetian A , Ali MK , Venkat Narayan KM . Rural diabetes prevalence quintuples over twenty-five years in low- and middle-income countries: a systematic review and meta-analysis. Diabetes Res Clin Pract . 2012;96(3):271–285. doi:10.1016/j.diabres.2011.12.001 22261096
  • Unnikrishnan R , Pradeepa R , Joshi SR , Mohan V . Type 2 diabetes: demystifying the global epidemic. Diabetes . 2017;66(6):1432–1442. doi:10.2337/db16-0766 28533294
  • Zimmet P , Taft P , Guinea A , Guthrie W , Thoma K . The high prevalence of diabetes mellitus on a Central Pacific island. Diabetologia . 1977;13(2):111–115. doi:10.1007/BF00745137 852640
  • Magliano DJ , Soderberg S , Zimmet PZ , et al. Explaining the increase of diabetes prevalence and plasma glucose in mauritius. Diabetes Care . 2012;35(1):87–91. doi:10.2337/dc11-0886 22100964
  • Dowse GK , Gareeboo H , Zimmet PZ , et al. High prevalence of NIDDM and impaired glucose tolerance in Indian, Creole, and Chinese Mauritians. Diabetes . 1990;39(3):390–396. doi:10.2337/diab.39.3.390 2307296
  • Ramachandran A , Mary S , Yamuna A , Murugesan N , Snehalatha C . High prevalence of diabetes and cardiovascular risk factors associated with urbanization in India. Diabetes Care . 2008;31(5):893–898. doi:10.2337/dc07-1207 18310309
  • Wang L , Gao P , Zhang M , et al. Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. JAMA . 2017;317(24):2515–2523. doi:10.1001/jama.2017.7596 28655017
  • Ning F , Pang ZC , Dong YH , et al. Risk factors associated with the dramatic increase in the prevalence of diabetes in the adult Chinese population in Qingdao, China. Diabetic Med . 2009;26(9):855–863. doi:10.1111/j.1464-5491.2009.02791.x 19719705
  • de Almeida-pititto B , Dias ML , de Moraes ACF , Ferreira SR , Franco DR , Eliaschewitz FG . Type 2 diabetes in Brazil: epidemiology and management. Diabetes Metab Syndr Obes . 2015;8:17–28. doi:10.2147/DMSO.S72542 25609989
  • Bertoldi AD , Kanavos P , França GVA , et al. Epidemiology, management, complications and costs associated with type 2 diabetes in Brazil: a comprehensive literature review. Global Health . 2013;9(1):62. doi:10.1186/1744-8603-9-62 24299125
  • Forouhi NG , Wareham NJ . Epidemiology of diabetes. Medicine . 2019;47(1):22–27. doi:10.1016/j.mpmed.2018.10.004
  • Lipscombe LL , Hux JE . Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995–2005: a population-based study. Lancet . 2007;369(9563):750–756. doi:10.1016/S0140-6736(07)60361-4 17336651
  • Mayer-Davis EJ , Lawrence JM , Dabelea D , et al. Incidence trends of type 1 and type 2 diabetes among youths, 2002–2012. N Engl J Med . 2017;376(15):1419–1429. doi:10.1056/NEJMoa1610187 28402773
  • Reece EA , Leguizamón G , Wiznitzer A . Gestational diabetes: the need for a common ground. Lancet . 2009;373(9677):1789–1797. doi:10.1016/S0140-6736(09)60515-8 19465234
  • Franco M , Bilal U , Ordunez P , et al. Population-wide weight loss and regain in relation to diabetes burden and cardiovascular mortality in Cuba 1980–2010: repeated cross sectional surveys and ecological comparison of secular trends. BMJ . 2013;346:f1515. doi:10.1136/bmj.f1515 23571838
  • Bommer C , Heesemann E , Sagalova V , et al. The global economic burden of diabetes in adults aged 20–79 years: a cost-of-illness study. Lancet Diabetes Endocrinol . 2017;5(6):423–430. doi:10.1016/S2213-8587(17)30097-9 28456416
  • American Diabetes Association. Hogan P , Dall T , Nikolov P . Economic costs of diabetes in the US in 2002. Diabetes Care . 2003;26(3):917–932. doi:10.2337/diacare.26.3.917 12610059
  • A. D. Association. Economic costs of diabetes in the U.S. in 2017. Diabetes Care . 2018;dci180007. doi:10.2337/dci18-0007
  • Herman WH . The economic costs of diabetes: is it time for a new treatment paradigm? Diabetes Care . 2013;36(4):775–776. doi:10.2337/dc13-0270 23520368
  • Chawla A , Chawla R , Jaggi S . Microvasular and macrovascular complications in diabetes mellitus: distinct or continuum? Indian J Endocrinol Metab . 2016;20(4):546–551. doi:10.4103/2230-8210.183480 27366724
  • Petrie JR , Guzik TJ , Touyz RM . Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Can J Cardiol . 2018;34(5):575–584. doi:10.1016/j.cjca.2017.12.005 29459239
  • Skinner MK . Epigenetic transgenerational inheritance. Nat Rev Endocrinol . 2016;12(2):68–70. doi:10.1038/nrendo.2015.206 26585656
  • Beckman JA , Paneni F , Cosentino F , Creager MA . Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II. Eur Heart J . 2013;34(31):2444–2452. doi:10.1093/eurheartj/eht142 23625211
  • Jonas JB , Sabanayagam C . Epidemiology and risk factors for diabetic retinopathy. Diabetic Retinopathy Cardiovasc Dis . 2019;27:20–37. doi:10.1159/000486262
  • Solomon SD , Chew E , Duh EJ , et al. Diabetic retinopathy: a position statement by the American Diabetes Association. Diabetes Care . 2017;40(3):412–418. doi:10.2337/dc16-2641 28223445
  • Feldman EL , Callaghan BC , Pop-Busui R , et al. Diabetic neuropathy. Nat Rev Dis Primers . 2019;5(1):1–8. doi:10.1038/s41572-019-0092-1 30617281
  • Watterworth B , Wright TB . Diabetic peripheral neuropathy. In: Abd-Elsayed A , editor. Pain: A Review Guide . Cham: Springer International Publishing; 2019:911–913.
  • Davies M , Brophy S , Williams R , Taylor A . The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care . 2006;29(7):1518–1522. doi:10.2337/dc05-2228 16801572
  • Khoury CC , Chen S , Ziyadeh FN . Chapter 19 - pathophysiology of diabetic nephropathy. In: Kimmel PL , Rosenberg ME , editors. Chronic Renal Disease . 2nd ed. Academic Press; 2020:279–296.
  • Steinke JM . The natural progression of kidney injury in young type 1 diabetic patients. Curr Diab Rep . 2009;9(6):473–479. doi:10.1007/s11892-009-0077-7 19954694
  • Harding JL , Pavkov ME , Magliano DJ , Shaw JE , Gregg EW . Global trends in diabetes complications: a review of current evidence. Diabetologia . 2019;62(1):3–16. doi:10.1007/s00125-018-4711-2 30171279
  • Krishnan B , Babu S , Walker J , Walker AB , Pappachan JM . Gastrointestinal complications of diabetes mellitus. World J Diabetes . 2013;4(3):51–63. doi:10.4239/wjd.v4.i3.51 23772273
  • Lin EHB , Rutter CM , Katon W , et al. Depression and advanced complications of diabetes: a prospective cohort study. Diabetes Care . 2010;33(2):264–269. doi:10.2337/dc09-1068 19933989
  • Tsilidis KK , Kasimis JC , Lopez DS , Ntzani EE , Ioannidis JPA . Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ . 2015;350. doi:10.1136/bmj.g7607.
  • Sözen T , Başaran NÇ , Tınazlı M , Özışık L . Musculoskeletal problems in diabetes mellitus. Eur J Rheumatol . 2018;5(4):258–265. doi:10.5152/eurjrheum.2018.18044 30388074
  • Wyatt LH , Ferrance RJ . The musculoskeletal effects of diabetes mellitus. J Can Chiropr Assoc . 2006;50(1):43–50.17549168
  • Bushby K , Finkel R , Birnkrant DJ , et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol . 2010;9(1):77–93. doi:10.1016/S1474-4422(09)70271-6 19945913
  • García JJM , Pérez GGR , Sicairos NML . Prevalencia de resistencia a la insulina y síndrome metabólico en niños obesos que acuden a la Clínica de Obesidad del Hospital Pediátrico de Sinaloa. Pediatr Mex . 2010;12(1):18–22.
  • Mesinovic J , Zengin A , De Courten B , Ebeling PR , Scott D . Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship. Diabetes Metab Syndr Obes . 2019;12:1057–1072. doi:10.2147/DMSO.S186600 31372016
  • Hong S , Chang Y , Jung HS , Yun KE , Shin H , Ryu S . Relative muscle mass and the risk of incident type 2 diabetes: a cohort study. PLoS One . 2017;12(11):e0188650. doi:10.1371/journal.pone.0188650 29190709
  • Yusof NA , Idris NS , Zin FM . Diabetic neuropathic cachexia in a young woman. Korean J Fam Med . 2019;40(3):194–198. doi:10.4082/kjfm.17.0127 30497111
  • Gibbons CH . Treatment-induced neuropathy of diabetes. Curr Diab Rep . 2017;17(12):127. doi:10.1007/s11892-017-0960-6 29064042
  • Tuomilehto J , Schwarz P , Lindström J . Long-term benefits from lifestyle interventions for type 2 diabetes prevention: time to expand the efforts. Diabetes Care . 2011;34(Supplement 2):S210–S214. doi:10.2337/dc11-s222 21525457
  • Gillies CL , Abrams KR , Lambert PC , et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ . 2007;334(7588):299. doi:10.1136/bmj.39063.689375.55 17237299
  • Schwarz PEH , Riemenschneider H . Slowing down the progression of type 2 diabetes: we need fair, innovative, and disruptive action on environmental and policy levels! Diabetes Care . 2016;39(Supplement 2):S121–S126. doi:10.2337/dcS15-3001 27440824
  • Cederholm J , Gudbjörnsdottir S , Eliasson B , et al. Blood pressure and risk of cardiovascular diseases in type 2 diabetes: further findings from the Swedish National Diabetes Register (NDR-BP II). J Hypertens . 2012;30(10):2020. doi:10.1097/HJH.0b013e3283577bdf 22871895
  • Eeg-Olofsson K , Cederholm J , Nilsson PM , et al. Glycemic control and cardiovascular disease in 7,454 patients with type 1 diabetes: an observational study from the Swedish National Diabetes Register (NDR). Diabetes Care . 2010;33(7):1640–1646. doi:10.2337/dc10-0398 20424222
  • Davis WA , Davis TME . Cardiovascular risk prediction in adults with type 1 diabetes: the Fremantle Diabetes Study. Diabetes Res Clin Pract . 2010;90(3):e75–e78. doi:10.1016/j.diabres.2010.09.015 20950885
  • Kautzky-Willer A , Stich K , Hintersteiner J , et al. Sex-specific-differences in cardiometabolic risk in type 1 diabetes: a cross-sectional study. Cardiovasc Diabetol . 2013;12(1):78. doi:10.1186/1475-2840-12-78 23705959
  • Koivisto VA , Stevens IK , Mattock M , et al. Cardiovascular disease and its risk factors in IDDM in Europe. Diabetes Care . 1996;19(7):689–697. doi:10.2337/diacare.19.7.689 8799621
  • Stettler C , Bearth A , Allemann S , et al. QTc interval and resting heart rate as long-term predictors of mortality in type 1 and type 2 diabetes mellitus: a 23-year follow-up. Diabetologia . 2007;50(1):186–194. doi:10.1007/s00125-006-0483-1 17096116
  • Atkinson MA , Eisenbarth GS , Michels AW . Type 1 diabetes. Lancet . 2014;383(9911):69–82. doi:10.1016/S0140-6736(13)60591-7 23890997
  • Ullah F , Afridi AK , Rahim F , et al. Knowledge of diabetic complications in patients with diabetes mellitus. J Ayub Med Coll Abbottabad . 2015;27(2):360–363.26411116
  • Saha S , Gerdtham U-G , Johansson P . Economic evaluation of lifestyle interventions for preventing diabetes and cardiovascular diseases. Int J Environ Res Public Health . 2010;7(8):3150–3195. doi:10.3390/ijerph7083150 20948954
  • Ramachandran A , Snehalatha C , Yamuna A , Mary S , Ping Z . Cost-effectiveness of the interventions in the primary prevention of diabetes among Asian Indians: within-trial results of the Indian diabetes prevention programme (IDPP). Diabetes Care . 2007;30(10):2548–2552. doi:10.2337/dc07-0150 17670917
  • Weber MB , Ranjani H , Staimez LR , et al. The stepwise approach to diabetes prevention: results from the D-CLIP randomized controlled trial. Diabetes Care . 2016;39(10):1760–1767. doi:10.2337/dc16-1241 27504014
  • Marín-Peñalver JJ , Martín-Timón I , Sevillano-Collantes C , Del Cañizo-Gómez FJ . Update on the treatment of type 2 diabetes mellitus. World J Diabetes . 2016;7(17):354–395. doi:10.4239/wjd.v7.i17.354 27660695
  • Álvarez-almazán S , Filisola-Villaseñor JG , Alemán-González-Duhart D , Tamay-Cach F , Mendieta-Wejebe JE . Current molecular aspects in the development and treatment of diabetes. J Physiol Biochem . 2020;76(1):13–35. doi:10.1007/s13105-019-00717-0 31925679
  • Teoh SL , Das S . Phytochemicals and their effective role in the treatment of diabetes mellitus: a short review. Phytochem Rev . 2018;17(5):1111–1128. doi:10.1007/s11101-018-9575-z
  • Mahomoodally MF , Mootoosamy A , Wambugu S . Traditional therapies used to manage diabetes and related complications in Mauritius: a comparative ethnoreligious study. Evid Based Complement Alternat Med . 2016;2016:1–25. doi:10.1155/2016/4523828
  • Maruthur NM , Tseng E , Hutfless S , et al. Diabetes medications as monotherapy or metformin-based combination therapy for type 2 diabetes. Ann Intern Med . 2016;164(11):740–751. doi:10.7326/M15-2650 27088241
  • Ezuruike UF , Prieto JM . The use of plants in the traditional management of diabetes in Nigeria: pharmacological and toxicological considerations. J Ethnopharmacol . 2014;155(2):857–924. doi:10.1016/j.jep.2014.05.055 24929108
  • Lee AL , Chen BC , Mou CH , Sun MF , Yen HR . Association of traditional Chinese medicine therapy and the risk of vascular complications in patients with type II diabetes mellitus. Medicine . 2016;95(3). doi:10.1097/MD.0000000000002536
  • Katiyar D , Singh V , Gilani SJ , Goel R , Grover P , Vats A . Hypoglycemic herbs and their polyherbal formulations: a comprehensive review. Med Chem Res . 2015;24(1):1–21. doi:10.1007/s00044-014-1080-3
  • Salehi B , Ata A , V Anil Kumar N , et al. Antidiabetic potential of medicinal plants and their active components. Biomolecules . 2019;9(10):551. doi:10.3390/biom9100551
  • Ríos JL , Francini F , Schinella GR . Natural products for the treatment of type 2 diabetes mellitus. Planta Med . 2015;81(12–13):975–994. doi:10.1055/s-0035-1546131 26132858
  • Arumugam G , Manjula P , Paari N . A review: anti diabetic medicinal plants used for diabetes mellitus. J Acute Dis . 2013;2(3):196–200. doi:10.1016/S2221-6189(13)60126-2